Synaptic plasticity in the ischaemic brain

Lancet Neurology

Volumn 2, Issue 10, 2003, Pages 622-629

  Calabresi, Paolo ^a,b   Centonze, Diego ^a   Pisani, Antonio ^a   Cupini, Letizia M ^a   Bernardi, Giorgio ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CALCIUM CHELATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; OXYGEN; PROTEIN KINASE C INHIBITOR; SCOPOLAMINE;

BLOOD CLOT LYSIS; BRAIN DEPTH STIMULATION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CORPUS STRIATUM; DRUG EFFECT; ENERGY; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; LONG TERM POTENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCANNING ELECTRON MICROSCOPY; STROKE;

EID: 0141738370     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00532-5     Document Type: Review

References (84)

1. Malenka R.C., Nicoll R.A. Long-term potentiation: a decade of progress? Science. 285:1999;1870-1874.
2. Martin S.J., Grimwood P.D., Morris R.G.M. Synaptic plasticity and memory: an evaluation hypothesis. Annu Rev Neurosci. 23:2000;649-711.
3. McEachern J.C., Shaw C.A. An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res Brain Res Rev. 22:1996;51-92.
4. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res. 58:1999;167-190.
5. Hughes P.E., Alexi T., Walton M., et al. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol. 57:1999;421-450.
6. Calabresi P., Picconi B., Saulle E., Centonze D., Hainsworth A.H., Bernardi G. Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke. 31:2000;766-772.
7. Hammond C., Crepel V., Gozlan H., Ben-Ari Y. Anoxic LTP sheds light on the multiple facets of NMDA receptors. Trends Neurosci. 17:1994;497-503.
8. Ben-Ari Y. Cell death and synaptic reorganizations produced by seizures. Epilepsia. 42:(suppl 3):2001;5-7.
9. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:1999;391-397.
10. Calabresi P., Centonze D., Bernardi G. Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology. 55:2000;1249-1255.
11. Centonze D., Marfia G.A., Pisani A., et al. Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons. Prog Neurobiol. 63:2001;687-696.
12. Calabresi P., Marfia G.A., Centonze D., Pisani A., Bernardi G. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. Stroke. 30:1999;171-179.
13. Gillardon F., Kiprianova I., Sandkuhler J., Hossmann K.A., Spranger M. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience. 93:1999;1219-1222.
14. Plum F. Neuroprotection in acute ischemic stroke. JAMA. 13:2001;1760-1761.
15. Crepel V., Hammond C., Krnjevic K., Chinestra P., Ben-Ari Y. Anoxia-induced LTP of isolated NMDA receptor-mediated synaptic responses. J Neurophysiol. 69:1993;1774-1778.
16. Crepel V., Ben-Ari Y. Intracellular injection of a Ca2+ chelator prevents generation of anoxic LTP. J Neurophysiol. 75:1996;770-779.
17. Crepel V., Hammond C., Chinestra P., Diabira D., Ben-Ari Y. A selective LTP of NMDA receptor-mediated currents induced by anoxia in CA1 hippocampal neurons. J Neurophysiol. 70:1993;2045-2055.
18. Gozlan H., Ben-Ari Y. NMDA receptor redox sites: are they targets for selective neuronal protection? Trends Pharmacol Sci. 16:1995;368-374.
19. Gozlan H., Diabira D., Chinestra P., Ben-Ari Y. Anoxic LTP is mediated by the redox modulatory site of the NMDA receptor. J Neurophysiol. 72:1994;3017-3022.
20. Hsu K.S., Huang C.C. Characterization of the anoxia-induced long-term synaptic potentiation in area CA1 of the rat hippocampus. Br J Pharmacol. 122:1997;671-681.
21. Hsu K.S., Huang C.C. Protein kinase C inhibitors block generation of anoxia-induced long-term potentiation. Neuroreport. 9:1998;3525-3529.
22. Huang C.C., Hsu K.S. Nitric oxide signalling is required for the generation of anoxia-induced long-term potentiation in the hippocampus. Eur J Neurosci. 9:1997;2202-2206.
23. Tekkok S., Krnjevic K. Long-term potentiation in hippocampal slices induced by temporary suppression of glycolysis. J Neurophysiol. 74:1995;2763-2766.
24. Tekkok S., Krnjevic K. Calcium dependence of LTP induced by 2-deoxyglucose in CA1 neurons. J Neurophysiol. 76:1996;2343-2352.
25. Zhao Y.T., Krnjevic K. 2-Deoxyglucose-induced long-term potentiation in CA1 is not prevented by intraneuronal chelator. J Neurophysiol. 83:2000;177-180.
26. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
27. Calabresi P., Centonze D., Pisani A., et al. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Ann Neurol. 43:1998;586-597.
28. Calabresi P., Saulle E., Centonze D., Pisani A., Marfia G.A., Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain. 125:2002;844-860.
29. Calabresi P., Saulle E., Marfia G.A., et al. Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum. Mol Pharmacol. 60:2001;808-815.
30. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 333:1995;1581-1587.
31. Kidwell C.S., Saver J.L., Starkman S., et al. Late ischemic injury in patients receiving 32 intraarterial thrombolysis. Ann Neurol. 52:2002;698-703.
32. Nicole O., Docagne F., Ali C., et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 7:2001;59-64.
33. Centonze D., Saulle E., Pisani A., et al. Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation. Neuroreport. 13:2002;115-118.
34. Yuste R., Bonhoeffer T. Morphological changes associated with long-term synaptic plasticity. Annu Rev Neurosci. 24:2001;1071-1089.
35. Piccini A., Malinow R. Transient oxygen-glucose deprivation induces rapid morphological changes in rat hippocampal dendrites. Neuropharmacology. 41:2001;724-729.
36. Jourdain P., Nikonenko I., Alberi S., Muller D. Remodeling of hippocampal synaptic networks by a brief anoxia-hypoglycemia. J Neurosci. 22:2002;3108-3116.
37. Martone M.E., Jones Y.Z., Young S.J., Ellisman M.H., Zivin J.A., Hu B.R. Modification of postsynaptic densities after transient cerebral ischemia: a quantitative and three-dimensional ultrastructural study. J Neurosci. 19:1999;1988-1997.
38. Martone M.E., Hu B.R., Ellisman M.H. Alterations of hippocampal postsynaptic densities following transient ischemia. Hippocampus. 10:2000;610-616.
39. Gao T.M., Xu Z.C. In vivo intracellular demonstration of an ischemia-induced postsynaptic potential from CA1 pyramidal neurons in rat hippocampus. Neuroscience. 75:1996;665-669.
40. Gao T.M., Pulsinelli W.A., Xu Z.C. Prolonged enhancement and depression of synaptic transmission in CA1 pyramidal neurons induced by transient forebrain ischemia in vivo. Neuroscience. 87:1998;371-383.
41. Gajendiran M., Ling G.Y., Pang Z., Xu Z.C. Differential changes of synaptic transmission in spiny neurons of rat neostriatum following transient forebrain ischemia. Neuroscience. 105:2001;139-152.
42. Pang Z.P., Deng P., Ruan Y.W., Xu Z.C. Depression of fast excitatory synaptic transmission in large aspiny neurons of the neostriatum after transient forebrain ischemia. J Neurosci. 22:2002;10948-10957.
43. Bolay H., Dalkara T. Mechanisms of motor dysfunction after transient MCA occlusion. Persistent transmission failure in cortical synapses is a major determinant. Stroke. 29:1998;1988-1994.
44. Bolay H., Gürsoy-Özdemir Y., Sara Y., Onur R., Can A., Dalkara T. Persistent defect in transmitter release and synapsin phosphorylation in cerebral cortex after transient moderate ischemic injury. Stroke. 33:2002;1369-1375.
45. Dryhurst G. Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders? Adv Exp Med Biol. 500:2001;373-396.
46. Kumral E., Evyapan D., Balkir K. Acute caudate vascular lesions. Stroke. 30:1999;100-108.
47. Bokura H., Robinson R.G. Long-term cognitive impairment associated with caudate stroke. Stroke. 28:1997;970-975.
48. Buyukuysal R.L., Mete B. Anoxia-induced dopamine release from rat striatal slices: involvement of reverse transport mechanism. J Neurochem. 72:1999;1507-1515.
49. Kondoh T., Lee S.H., Low W.C. Alterations in striatal dopamine release and reuptake under conditions of mild, moderate, and severe cerebral ischemia. Neurosurgery. 37:1995;948-954.
50. Calabresi P., Pisani A., Mercuri N.B., Bernerdi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19:1996;19-24.
51. Saulle E., Centonze D., Martin A.B., Moratalla R., Bernardi G., Calabresi P. Endogenous dopamine amplifies ischemic long-lerm potentiation via D1 receptors. Stroke. 33:2002;2978-2984.
52. Korten A., Lodder J., Vreeling F., Boreas A., van Raak L., Kessels F. Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke? Mov Disord. 16:2001;119-123.
53. Furukawa N., Arai N., Goshima Y., et al. Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata. J Neurochem. 76:2001;815-824.
54. Toner C.C., Stamford J.A. "Real time" measurement of dopamine release in an in vitro model of neostriatal ischemia. J Neurosci Methods. 67:1996;133-140.
55. Buisson A., Callebert J., Mathieu E., Plotkine M., Boulu R.G. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J Neurochem. 59:1992;1153-1157.
56. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab. 22:2002;1283-1296.
57. Kawai K., Nakagomi T., Kirino T., Tamura A., Kawai N. Preconditioning in vivo ischemia inhibits anoxic long-term potentiation and functionally protects CA1 neurons in the gerbil. J Cereb Blood Flow Metab. 18:1998;288-296.
58. Lee J., Duan W., Mattson M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem. 82:2002;1367-1375.
59. Duan W., Guo Z., Jiang H., Ware M., Li X.J., Mattson M.P. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA. 100:2003;2911-2916.
60. Mattson M.P., Duan W., Guo Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem. 84:2003;417-431.
61. Hallett M. Plasticity of the human motor cortex and recovery from stroke. Brain Res Brain Res Rev. 36:2001;169-174.
62. Rijntjes M., Weiller C. Recovery of motor and language abilities after stroke: the contribution of functional imaging. Prog Neurobiol. 66:2002;109-122.
63. Hagemann G., Redecker C., Neumann-Haefelin T., Freund H.J., Witte O.W. Increased long-term potentiation in the surround of experimentally induced focal cortical infarction. Ann Neurol. 44:1998;255-258.
64. Reinecke S., Lutzenburg M., Hagemann G., Bruehl C., Neumann-Haefelin T., Witte O.W. Electrophysiological transcortical diaschisis after middle cerebral artery occlusion in rats. Neurosci Lett. 261:1999;85-88.
65. Que M., Schiene K., Witte O.W., Zilles K. Widespread up-regulation of N-methyl-D-aspartate receptors after focal photothrombotic lesion in rat brain. Neurosci Lett. 273:1999;77-80.
66. Buchkremer-Ratzmann I., August M., Hagemann G., Witte O.W. Electrophysiological transcortical diaschisis after cortical photothrombosis in rat brain. Stroke. 27:1996;1105-1111.
67. Rossini P.M., Calautti C., Pauri F., Baron J.-C. Post-stroke plastic reorganisation in the adult brain. Lancet Neurology. 2:2003;493-502.
68. Johansson B.B., Belichenko P.V. Neuronal plasticity and dendritic spines: effect of environmental enrichment on intact and postischemic rat brain. J Cereb Blood Flow Metab. 22:2002;89-96.
69. Biernaskie J., Corbett D. Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury. J Neurosci. 21:2001;5272-5280.
70. Scheidtmann K., Fries W., Muller F., Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet. 358:2001;787-790.
71. Hossmann K.A. Viability threshold and the penumbra of focal ischemia. Ann Neurol. 36:1994;557-565.
72. Heiss W.D. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 20:2000;1276-1293.
73. Warach S. New imaging strategies for patient selection for thrombolytic and neuroprotective therapies. Neurology. 57:(suppl 2):2001;S48-S52.
74. Keir S.L., Wardlaw J.M. Systematic review of diffusion and perfusion imaging in acute ischemic stroke. Stroke. 31:2000;272-331.
75. Pulsinelli W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res. 63:1985;29-37.
76. Roy M., Sapolsky R. Neuronal apoptosis in acute necrotic insults: why is this subject such a mess? Trends Neurosci. 22:1999;419-422.
77. Colbourne F., Li H., Buchan A.M., Clemens J.A. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke. 30:1999;662-668.
78. Lee J.-M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:(suppl 1):1999;A7-A14.
79. Ghosh A., Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
80. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23:2000;222-229.
81. Legos J.J., Tuma R.F., Barone F.C. Pharmacological interventions for stroke: failures and future. Exp Opin Invest Drugs. 11:2002;603-614.
82. Aarts M., Liu Y., Liu L., et al. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science. 298:2002;846-850.
83. Mattson M.P. Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol. 10:2000;300-312.
84. Gillardon F., Kiprianova I., Sandkuhler J., Hossmann K.A., Spranger M. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience. 93:1999;1219-1222.